Jacobs Growth Could Improve on Data Centers, Life Sciences Demand, RBC Says

MT Newswires Live
05/20

Jacobs (J) could see stronger growth in H2 as data center demand, Life Sciences work, US infrastructure spending, AI use and shareholder returns support the outlook, RBC Capital Markets said in a note Monday.

Jacobs' demand backdrop remains healthy, with Life Sciences and Advanced Facilities expected to improve further in H2, and the company is already seeing better growth, helped by higher net revenue in fiscal Q1 and fiscal Q2, the investment firm said.

RBC said about 10% of Jacobs' business is linked to the AI market, including data centers, power, energy and semiconductors, with demand supported by hyperscalers and neocloud companies, adding that Jacobs could win more work from Hut 8 (HUT) after securing a second AI data center project, helped by its growing relationship with the customer and its data center work with Nvidia (NVDA).

The US infrastructure outlook also remains supportive, with about half of the $500 billion IIJA funding allocated and a possible surface transportation reauthorization later this year, according to the note.

RBC kept the company's outperform rating and $169 price target.

Price: 114.11, Change: +0.50, Percent Change: +0.44

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10